StreetAlpha
13F holdings · Q3 2026

Eventide Asset Management

Boston, MA · files as Eventide Asset Management, LLC
Know the moment Eventide Asset Management filesYou follow Eventide Asset Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1442891

Eventide Asset Management reported 347 stocks worth $7.1B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are GH (4.7%), XMTR (3.1%) and TT (2.6%). Compared with Q2 2026, the fund opened new positions in PLD, AGEN and ALAB, added to TT, TRGP and BBNX, trimmed GH, LRCX and ASML and sold out of BBIO, AMLX and SION.

Latest filing: what Eventide Asset Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
65 new191 added60 trimmed19 sold outBought about $469M · sold about $493M
New 65
See all 65 →
Added 191
See all 191 →
Trimmed 60
  • LRCX−$33.9M−15%
  • KLAC−$31.8M−48%
  • DELL−$31.6M−32%
  • GEV−$29.1M−29%
  • GH−$17.5M−5%
See all 60 →
Sold out 19
See all 19 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$7.1B−4.6% vs last quarter
Stocks held34765 new · 19 sold out
Top 5 weight14.9%spread out
Turnover22%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
GH
Guardant Health Inc
$332M4.7%1.9M−98K (−5%)8 of 8
2
XMTR
Xometry Inc
$221M3.1%2.2MNo change8 of 8
3
TT
Trane Technologies PLC
$189M2.6%419K+3,799 (+1%)8 of 8
4
LRCX
Lam Research Corp
$187M2.6%570K−103K (−15%)8 of 8
5
TRGP
Targa Res Corp
$135M1.9%497K+6,499 (+1%)8 of 8
6
BBNX
Beta Bionics Inc
$134M1.9%7M+791K (+13%)7 of 8
7
ASML
Asml Holding N V
$123M1.7%68K−400 (−1%)8 of 8
8
URI
United Rentals Inc
$114M1.6%114K+10K (+10%)7 of 8
9
MIRM
Mirum Pharmaceuticals Inc
$107M1.5%1.2MNo change8 of 8
10
ARGX
Argenx SE
$106M1.5%111K−15K (−12%)8 of 8
🔒 337 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
APOGEE THERAPEUTICS INC
$34.5M260K
BBIO
Bridgebio Pharma Inc
$32.6M437K
AMLX
Amylyx Pharmaceuticals Inc
$23.8M1.3M
SION
Sionna Therapeutics Inc
$20.9M475K
STRO
Sutro Biopharma Inc
$19.4M585K

🔒 Free account: see all 19.

Reported value

last 8 quarters
$5.5BQ4 '24
$5BQ1 '25
$5.7BQ2 '25
$6.1BQ3 '25
$6.4BQ4 '25
$6BQ1 '26
$7.5BQ2 '26
$7.1BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Eventide Asset Management 13F FAQ

What does Eventide Asset Management own?

Eventide Asset Management reported 347 stocks worth $7.1B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are GH (4.7%), XMTR (3.1%) and TT (2.6%). The table above lists every position in the filing (the top 10 without an account).

What did Eventide Asset Management buy and sell in Q3 2026?

Compared with Q2 2026: 65 new positions, 191 added to, 60 trimmed and 19 sold out. New positions include PLD, AGEN and ALAB. It sold all of BBIO, AMLX and SION.

When will Eventide Asset Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Eventide Asset Management's portfolio worth?

The Q3 2026 filing reports $7.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.